Indirect-acting dopaminergic drugs, such as monoamine oxidase inhibitors (MAOIs), are given to __________ the needed dose of levodopa.

Prepare for the EDAPT Intracranial Regulation Test with interactive flashcards and multiple choice questions. Each question is accompanied by helpful hints and explanations to boost your readiness. Get started today and ensure your success!

Multiple Choice

Indirect-acting dopaminergic drugs, such as monoamine oxidase inhibitors (MAOIs), are given to __________ the needed dose of levodopa.

Explanation:
Indirect-acting dopaminergic drugs like MAO inhibitors boost dopamine levels by slowing its breakdown in the brain. Because dopamine persists longer and signaling is enhanced, you can reach the same therapeutic effect with a smaller amount of levodopa. So these drugs are used to decrease the needed dose of levodopa, not to increase it. The idea is that preserving and prolonging dopaminergic activity reduces how much levodopa is required to control symptoms.

Indirect-acting dopaminergic drugs like MAO inhibitors boost dopamine levels by slowing its breakdown in the brain. Because dopamine persists longer and signaling is enhanced, you can reach the same therapeutic effect with a smaller amount of levodopa. So these drugs are used to decrease the needed dose of levodopa, not to increase it. The idea is that preserving and prolonging dopaminergic activity reduces how much levodopa is required to control symptoms.

More Multiple Choice Questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy